[HTML][HTML] SARS-CoV-2 breakthrough infection in vaccinees induces virus-specific nasal-resident CD8+ and CD4+ T cells of broad specificity
Journal of Experimental Medicine, 2022•rupress.org
SARS-CoV-2 breakthrough infection in vaccinees induces virus-specific nasal-resident CD8+
and CD4+ T cells of broad specificity | Journal of Experimental Medicine | Rockefeller
University Press Skip to Main Content Advertisement Umbrella Alt Text Umbrella Alt Text Close
About the Press Our Philosophy Our Staff Our History About the University Contact Us Advertise
For Librarians Rights & Permissions Permissions & Licensing Terms of Use Copyright Agent
Publication Fees License to Publish: Gold OA License to Publish: Green OA Privacy Policy …
and CD4+ T cells of broad specificity | Journal of Experimental Medicine | Rockefeller
University Press Skip to Main Content Advertisement Umbrella Alt Text Umbrella Alt Text Close
About the Press Our Philosophy Our Staff Our History About the University Contact Us Advertise
For Librarians Rights & Permissions Permissions & Licensing Terms of Use Copyright Agent
Publication Fees License to Publish: Gold OA License to Publish: Green OA Privacy Policy …
Disclosures: A. Bertoletti, AT Tan, and N. Le Bert reported a patent for a method to monitor SARS-CoV-2–specific T cells in biological samples pending and licensed (Hyris). No other disclosures were reported.
rupress.org
